Phenotyping of P105-negative B cell subsets in patients with systemic lupus erythematosus

14Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This study aimed to investigate phenotype of RP105(-) B cell subsets in patients with systemic lupus erythematosus (SLE). Flow cytometry was used for phenotyping RP105-negaive B cell subsets. Based on CD19, RP105, and CD138 expression, RP105(-) B cells consist of at least 5 subsets of late B cells, including CD19(+)RP105(int), CD19(+) RP105(-), CD19(low) RP105(-) CD138(-), CD19(low) RP105(-)CD138(int), and CD19(low) RP105(-) CD138(++) B cells. Especially, CD19(+)RP105(int) and CD19(low) RP105(-)CD138(int) B cells are significantly larger than other RP105(-) B cell subsets in SLE. By comparison of RP105(-) B cell subsets between patients with SLE and normal subjects, these subsets were detectable even in normal subjects, but the percentages of RP105(-) B cell subsets were significantly larger in SLE. The phenotypic analysis of RP105(-) B cell subsets suggests dysregulation of later B cell subsets in SLE and may provide new insights into understanding regulation of B cells in human SLE. Copyright © 2012 Syuichi Koarada et al.

Cite

CITATION STYLE

APA

Koarada, S., Tada, Y., Suematsu, R., Soejima, S., Inoue, H., Ohta, A., & Nagasawa, K. (2012). Phenotyping of P105-negative B cell subsets in patients with systemic lupus erythematosus. Clinical and Developmental Immunology, 2012. https://doi.org/10.1155/2012/198206

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free